PortfoliosLab logoPortfoliosLab logo
NDSN vs. WST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NDSN vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nordson Corporation (NDSN) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both stocks are quite close, with NDSN having a 20.24% return and WST slightly lower at 19.71%. Over the past 10 years, NDSN has underperformed WST with an annualized return of 14.17%, while WST has yielded a comparatively higher 16.30% annualized return.


NDSN

1D
0.90%
1M
3.33%
YTD
20.24%
6M
23.21%
1Y
34.03%
3Y*
8.35%
5Y*
6.49%
10Y*
14.17%

WST

1D
-0.46%
1M
8.74%
YTD
19.71%
6M
23.10%
1Y
46.68%
3Y*
-2.51%
5Y*
-0.72%
10Y*
16.30%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NDSN vs. WST - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NDSN
Nordson Corporation
20.24%17.03%-20.15%12.39%-5.93%28.09%24.45%37.88%-17.65%31.83%
WST
West Pharmaceutical Services, Inc.
19.71%-15.73%-6.75%49.97%-49.70%65.88%89.05%54.13%-0.08%17.02%

Correlation

The correlation between NDSN and WST is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.41

Correlation (5Y)
Calculated over the trailing 5-year period

0.47

Correlation (10Y)
Calculated over the trailing 10-year period

0.45

Correlation (All Time)
Calculated using the full available price history since Mar 26, 1990

0.35

The correlation between NDSN and WST shifts across timeframes, from 0.35 (all time) to 0.47 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NDSN:

$16.17B

WST:

$23.81B

EPS

NDSN:

$9.36

WST:

$7.47

PE Ratio

NDSN:

30.79

WST:

44.02

PS Ratio

NDSN:

5.60

WST:

7.42

PB Ratio

NDSN:

5.05

WST:

7.96

Total Revenue (TTM)

NDSN:

$2.90B

WST:

$3.22B

Gross Profit (TTM)

NDSN:

$1.60B

WST:

$1.17B

EBITDA (TTM)

NDSN:

$744.50M

WST:

$799.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NDSN vs. WST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NDSN
NDSN Risk / Return Rank: 8282
Overall Rank
NDSN Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
NDSN Sortino Ratio Rank: 8383
Sortino Ratio Rank
NDSN Omega Ratio Rank: 7878
Omega Ratio Rank
NDSN Calmar Ratio Rank: 8080
Calmar Ratio Rank
NDSN Martin Ratio Rank: 8484
Martin Ratio Rank

WST
WST Risk / Return Rank: 7676
Overall Rank
WST Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
WST Sortino Ratio Rank: 8080
Sortino Ratio Rank
WST Omega Ratio Rank: 7777
Omega Ratio Rank
WST Calmar Ratio Rank: 7575
Calmar Ratio Rank
WST Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NDSN vs. WST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nordson Corporation (NDSN) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NDSNWSTDifference
Sharpe ratioReturn per unit of total volatility

+0.47

Sortino ratioReturn per unit of downside risk

+0.18

Omega ratioGain probability vs. loss probability

1.27

1.26

+0.01

Calmar ratioReturn relative to maximum drawdown

2.42

1.90

+0.52

Martin ratioReturn relative to average drawdown

7.81

3.81

+4.01

NDSN vs. WST - Sharpe Ratio Comparison

The current NDSN Sharpe Ratio is 1.61, which is higher than the WST Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of NDSN and WST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NDSN vs. WST - Drawdown Comparison

The maximum NDSN drawdown since its inception was -73.62%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for NDSN and WST.


Loading charts...

Drawdown Indicators


NDSNWSTDifference

Max Drawdown

Largest peak-to-trough decline

-73.62%

-59.29%

-14.33%

Max Drawdown (1Y)

Largest decline over 1 year

-14.15%

-24.70%

+10.55%

Max Drawdown (3Y)

Largest decline over 3 years

-39.15%

-53.79%

+14.64%

Max Drawdown (5Y)

Largest decline over 5 years

-39.15%

-59.29%

+20.14%

Max Drawdown (10Y)

Largest decline over 10 years

-44.24%

-59.29%

+15.05%

Current Drawdown

Current decline from peak

-3.41%

-29.39%

+25.98%

Average Drawdown

Average peak-to-trough decline

-13.24%

-16.89%

+3.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.37%

12.30%

-7.93%

Volatility

NDSN vs. WST - Volatility Comparison

Nordson Corporation (NDSN) has a higher volatility of 8.59% compared to West Pharmaceutical Services, Inc. (WST) at 7.48%. This indicates that NDSN's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NDSNWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.59%

7.48%

+1.11%

Volatility (6M)

Calculated over the trailing 6-month period

15.87%

25.29%

-9.42%

Volatility (1Y)

Calculated over the trailing 1-year period

21.26%

41.32%

-20.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.78%

40.59%

-15.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.47%

34.65%

-6.18%

Dividends

NDSN vs. WST - Dividend Comparison

NDSN's dividend yield for the trailing twelve months is around 1.12%, more than WST's 0.26% yield.


PositionTTM20252024202320222021202020192018201720162015
NDSN
Nordson Corporation
1.12%1.66%1.02%1.01%0.98%0.71%0.77%0.90%1.09%0.78%0.91%1.43%
WST
West Pharmaceutical Services, Inc.
0.26%0.31%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%

Financials

NDSN vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Nordson Corporation and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M650.00M700.00M750.00M800.00M850.00M20222023202420252026
740.85M
844.90M
(NDSN) Total Revenue
(WST) Total Revenue
Values in USD except per share items

NDSN vs. WST - Profitability Comparison

The chart below illustrates the profitability comparison between Nordson Corporation and West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

35.0%40.0%45.0%50.0%55.0%20222023202420252026
54.5%
35.1%
Portfolio components
NDSN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nordson Corporation reported a gross profit of 404.08M and revenue of 740.85M. Therefore, the gross margin over that period was 54.5%.

WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a gross profit of 296.40M and revenue of 844.90M. Therefore, the gross margin over that period was 35.1%.

NDSN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nordson Corporation reported an operating income of 197.20M and revenue of 740.85M, resulting in an operating margin of 26.6%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported an operating income of 177.10M and revenue of 844.90M, resulting in an operating margin of 21.0%.

NDSN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nordson Corporation reported a net income of 117.32M and revenue of 740.85M, resulting in a net margin of 15.8%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, West Pharmaceutical Services, Inc. reported a net income of 138.80M and revenue of 844.90M, resulting in a net margin of 16.4%.


Frequently Asked Questions


NDSN and WST have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NDSN has higher volatility (8.59%) compared to WST (7.48%). In terms of maximum drawdown, NDSN dropped -73.62% vs WST's -59.29%.

NDSN currently has the higher Sharpe Ratio (1.61 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NDSN and WST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer